Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Bladder Cancer

<< Previous

Bullboard Posts

Next >>

Comment by fredgoodwinsonon Jul 22, 2021 5:12pm

210 Views

Post# 33591577

RE:RE:RE:RE:Bladder Cancer

Well John it`s certainly the case that pending results for 3 of those who received the optimised treatment ab initio are eagerly awaited to say the least and were they all to exhibit CRs then there would be good grounds for optimism.

Can`t shake off the conviction that the market is telling the way it is but then have maybe been here far too long.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec